loading
Schlusskurs vom Vortag:
$5.91
Offen:
$5.13
24-Stunden-Volumen:
410.58K
Relative Volume:
1.49
Marktkapitalisierung:
$11.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.31M
KGV:
-10.59
EPS:
-0.54
Netto-Cashflow:
$-7.46M
1W Leistung:
+56.97%
1M Leistung:
+20.01%
6M Leistung:
+3.55%
1J Leistung:
-62.86%
1-Tages-Spanne:
Value
$4.80
$5.96
1-Wochen-Bereich:
Value
$2.31
$6.69
52-Wochen-Spanne:
Value
$2.31
$15.40

Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile

Name
Firmenname
Coeptis Therapeutics Holdings Inc
Name
Telefon
724-934-6467
Name
Adresse
105 BRADFORD ROAD, SUITE 420, WEXFORD
Name
Mitarbeiter
7
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
COEP's Discussions on Twitter

Vergleichen Sie COEP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
 icon
COEP
COEPTIS THERAPEUTICS INC
0.415 2.70M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.29 612.00M 2.07B -1.42B -1.37B -0.6765
 icon
GOODO
Gladstone Commercial Corporation
20.65 372.90M 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
0.82 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.01 129.62M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
3.65 47.48M 0 0 0 0.00

Coeptis Therapeutics Holdings Inc Aktie (COEP) Neueste Nachrichten

pulisher
Jan 04, 2025

Coeptis Therapeutics Holdings Inc (NASDAQ: COEP): Getting A Free Pass? - Stocks Register

Jan 04, 2025
pulisher
Jan 03, 2025

Stock market today: Heartcore Enterprises -20.07%, Caravelle International -16.63% among biggest losers in early trading - Business Upturn

Jan 03, 2025
pulisher
Jan 02, 2025

Coeptis Therapeutics (COEP) Stock Gains Pre-Hour Traction - Stocks Telegraph

Jan 02, 2025
pulisher
Jan 01, 2025

Coeptis Therapeutics Expands License Agreement with University of Pittsburgh to Include SNAP-CAR NK Cell Technology - Marketscreener.com

Jan 01, 2025
pulisher
Jan 01, 2025

Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development - Marketscreener.com

Jan 01, 2025
pulisher
Dec 31, 2024

Coeptis Therapeutics Holdings, Inc. Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK - Marketscreener.com

Dec 31, 2024
pulisher
Dec 31, 2024

Coeptis Therapeutics Holdings, Inc. signed a binding Letter of Intent to acquire NexGenAI Affiliates Network from NexGenAI Solutions Group, Inc. - Marketscreener.com

Dec 31, 2024
pulisher
Dec 31, 2024

PHLX Swiss Franc (XDS) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

S&P 500 Health Care [Sector] (SRHC) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

S&P 500 Consumer Discretionary [Sector] (SRCD) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

KBW Property & Casualty Index (KPX) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

Trading Halt Occurred During This Micro Cap's EOY Surge - MSN

Dec 31, 2024
pulisher
Dec 31, 2024

Midday Market Movers: Biggest Stock Declines of the Day – Stock Market - HPBL

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market news: Coeptis Therapeutics Holdings declined by 96.03% whereas Baird Medical Investment Holdings +496.89% during mid day trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market today: Coeptis Therapeutics Holdings plunged by 95.98% whereas Baird Medical Investment Holdings gained over 201.90% in early trading - Business Upturn

Dec 31, 2024
pulisher
Dec 28, 2024

Coeptis Therapeutics announces reverse stock split - MSN

Dec 28, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics announces reverse stock split plan to remain on the Nasdaq - The Business Journals

Dec 27, 2024
pulisher
Dec 27, 2024

Why Is Coeptis Therapeutics Stock Falling On Friday? - Yahoo Finance

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics Announced an Acquisition and a New Divison Launch - Martechcube

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics Announces Reverse Stock Split - Lelezard

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics announces 1-for-20 reverse stock split - Investing.com

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics (COEP) Announces 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing - StockTitan

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis expands with AI platform acquisition and new tech division By Investing.com - Investing.com Canada

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics Announces Reverse Stock Split (PR Newswire) - Aktiellt

Dec 27, 2024
pulisher
Dec 26, 2024

Coeptis Therapeutics completes acquisition of AI company, launching technology division - The Business Journals

Dec 26, 2024
pulisher
Dec 26, 2024

Coeptis Therapeutics Holdings, Inc. completed the acquisition of NexGenAI Affiliates Network from NexGenAI Solutions Group, Inc. - Marketscreener.com

Dec 26, 2024
pulisher
Dec 26, 2024

Stock market today: Millennium Group International surged by 318.96% while SciSparc increased by 153.01% in early trading - Business Upturn

Dec 26, 2024
pulisher
Dec 26, 2024

Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies - IT News Online

Dec 26, 2024
pulisher
Dec 26, 2024

Coeptis expands with AI platform acquisition and new tech division - Investing.com

Dec 26, 2024
pulisher
Dec 21, 2024

Coeptis Therapeutics Holdings, Inc. Reports Voting Results from Annual Meeting - Defense World

Dec 21, 2024
pulisher
Dec 20, 2024

COEP Stock Plummets to 52-Week Low at $0.15 Amid Market Challenges - Investing.com Canada

Dec 20, 2024
pulisher
Dec 17, 2024

Short Interest in Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Increases By 11.0% - Defense World

Dec 17, 2024
pulisher
Dec 14, 2024

Financial Comparison: Coeptis Therapeutics (NASDAQ:COEP) & PharmaCyte Biotech (NASDAQ:PMCB) - Defense World

Dec 14, 2024
pulisher
Dec 12, 2024

Coeptis launching technology division with AI and data security-focused acquisitions - The Business Journals

Dec 12, 2024
pulisher
Dec 12, 2024

Coeptis Launches New Technology Division - Contract Pharma

Dec 12, 2024
pulisher
Dec 12, 2024

Coeptis Therapeutics Unveils New Technology Division: Coeptis Te - GuruFocus.com

Dec 12, 2024
pulisher
Dec 12, 2024

Coeptis Therapeutics launches tech division, eyes data security - Investing.com

Dec 12, 2024
pulisher
Dec 12, 2024

Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies - Marketscreener.com

Dec 12, 2024
pulisher
Dec 12, 2024

Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 12, 2024
pulisher
Dec 11, 2024

Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 04, 2024

Coeptis Therapeutics to Acquire NexGenAI for Enhanced AI Tools By Investing.com - Investing.com South Africa

Dec 04, 2024
pulisher
Dec 04, 2024

Coeptis Therapeutics Holdings to Acquire NexGenAI Affiliates Network, - citybiz

Dec 04, 2024
pulisher
Dec 03, 2024

Coeptis Therapeutics to Acquire NexGenAI for Enhanced AI Tools - Investing.com India

Dec 03, 2024
pulisher
Dec 03, 2024

Coeptis Acquires AI-Powered Marketing Platform - Contract Pharma

Dec 03, 2024
pulisher
Dec 03, 2024

Coeptis Therapeutics takes steps to acquire NexGenAI Affiliates Network - The Business Journals

Dec 03, 2024
pulisher
Dec 03, 2024

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries - PR Newswire

Dec 03, 2024
pulisher
Dec 02, 2024

Could BigBear.ai Become the Next Palantir Technologies? - AOL

Dec 02, 2024

Finanzdaten der Coeptis Therapeutics Holdings Inc-Aktie (COEP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Coeptis Therapeutics Holdings Inc-Aktie (COEP) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
DeSilva Tara
Director
Jan 12 '24
Buy
0.58
2,266
1,305
32,266
Mehalick David
CEO and President
Jan 08 '24
Buy
0.66
20,004
13,263
2,782,615
$18.24
price down icon 0.60%
$21.47
price up icon 2.24%
$356.33
price down icon 1.08%
$42.18
price up icon 0.43%
$184.71
price up icon 0.49%
$115.79
price up icon 0.42%
Kapitalisierung:     |  Volumen (24h):